675 related articles for article (PubMed ID: 35254121)
21. Unexpected high frequency of unspecific reactivities by testing pre-epidemic blood specimens from Europe and Africa with SARS-CoV-2 IgG-IgM antibody rapid tests points to IgM as the Achilles heel.
Mboumba Bouassa RS; Péré H; Tonen-Wolyec S; Longo JD; Moussa S; Mbopi-Keou FX; Mossoro-Kpinde CD; Grésenguet G; Veyer D; Bélec L
J Med Virol; 2021 Apr; 93(4):2196-2203. PubMed ID: 33107601
[TBL] [Abstract][Full Text] [Related]
22. SARS-CoV-2 Antibody Rapid Tests: Valuable Epidemiological Tools in Challenging Settings.
Saluzzo F; Mantegani P; Poletti De Chaurand V; Quaresima V; Cugnata F; Di Serio C; Macé A; De Vos M; Sacks JA; Cirillo DM
Microbiol Spectr; 2021 Oct; 9(2):e0025021. PubMed ID: 34549999
[TBL] [Abstract][Full Text] [Related]
23. Clinical diagnostic performance evaluation of five immunoassays for antibodies to SARS-CoV-2 diagnosis in a real-life routine care setting.
Akyala AI; Awayimbo JR; Ogo AC; Chima NJ; Billyrose OMA; Engom AOG
Pan Afr Med J; 2021; 39():3. PubMed ID: 34178231
[TBL] [Abstract][Full Text] [Related]
24. Rapid Quantitative Point-Of-Care Diagnostic Test for Post COVID-19 Vaccination Antibody Monitoring.
Moeller ME; Engsig FN; Bade M; Fock J; Pah P; Soerensen AL; Bang D; Donolato M; Benfield T
Microbiol Spectr; 2022 Apr; 10(2):e0039622. PubMed ID: 35357223
[TBL] [Abstract][Full Text] [Related]
25. Robust validation and performance comparison of immunogenicity assays assessing IgG and neutralizing antibodies to SARS-CoV-2.
Bonhomme ME; Bonhomme CJ; Strelow L; Chaudhari A; Howlett A; Breidenbach C; Hester J; Hammond C; Fuzy M; Harvey L; Swanner V; Ellis J; Greway RR; Pisciella VA; Green T; Kierstead L
PLoS One; 2022; 17(2):e0262922. PubMed ID: 35130298
[TBL] [Abstract][Full Text] [Related]
26. Clinical validation of the Siemens quantitative SARS-CoV-2 spike IgG assay (sCOVG) reveals improved sensitivity and a good correlation with virus neutralization titers.
Irsara C; Egger AE; Prokop W; Nairz M; Loacker L; Sahanic S; Pizzini A; Sonnweber T; Holzer B; Mayer W; Schennach H; Loeffler-Ragg J; Bellmann-Weiler R; Hartmann B; Tancevski I; Weiss G; Binder CJ; Anliker M; Griesmacher A; Hoermann G
Clin Chem Lab Med; 2021 Jul; 59(8):1453-1462. PubMed ID: 33837679
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of commercially available fully automated and ELISA-based assays for detecting anti-SARS-CoV-2 neutralizing antibodies.
Zedan HT; Yassine HM; Al-Sadeq DW; Liu N; Qotba H; Nicolai E; Pieri M; Bernardini S; Abu-Raddad LJ; Nasrallah GK
Sci Rep; 2022 Nov; 12(1):19020. PubMed ID: 36347859
[TBL] [Abstract][Full Text] [Related]
28. Diagnosis value of SARS-CoV-2 antigen/antibody combined testing using rapid diagnostic tests at hospital admission.
Veyrenche N; Bolloré K; Pisoni A; Bedin AS; Mondain AM; Ducos J; Segondy M; Montes B; Pastor P; Morquin D; Makinson A; Le Moing V; Van de Perre P; Foulongne V; Tuaillon E
J Med Virol; 2021 May; 93(5):3069-3076. PubMed ID: 33554363
[TBL] [Abstract][Full Text] [Related]
29. Evaluation of Three Quantitative Anti-SARS-CoV-2 Antibody Immunoassays.
Chapuy-Regaud S; Miédougé M; Abravanel F; Da Silva I; Porcheron M; Fillaux J; Diméglio C; Izopet J
Microbiol Spectr; 2021 Dec; 9(3):e0137621. PubMed ID: 34937195
[TBL] [Abstract][Full Text] [Related]
30. Comparison of two commercial surrogate ELISAs to detect a neutralising antibody response to SARS-CoV-2.
Müller K; Girl P; von Buttlar H; Dobler G; Wölfel R
J Virol Methods; 2021 Jun; 292():114122. PubMed ID: 33705832
[TBL] [Abstract][Full Text] [Related]
31. Development and clinical application of a rapid IgM-IgG combined antibody test for SARS-CoV-2 infection diagnosis.
Li Z; Yi Y; Luo X; Xiong N; Liu Y; Li S; Sun R; Wang Y; Hu B; Chen W; Zhang Y; Wang J; Huang B; Lin Y; Yang J; Cai W; Wang X; Cheng J; Chen Z; Sun K; Pan W; Zhan Z; Chen L; Ye F
J Med Virol; 2020 Sep; 92(9):1518-1524. PubMed ID: 32104917
[TBL] [Abstract][Full Text] [Related]
32. Overview of Neutralization Assays and International Standard for Detecting SARS-CoV-2 Neutralizing Antibody.
Liu KT; Han YJ; Wu GH; Huang KA; Huang PN
Viruses; 2022 Jul; 14(7):. PubMed ID: 35891540
[TBL] [Abstract][Full Text] [Related]
33. Specificity of SARS-CoV-2 Antibody Detection Assays against S and N Proteins among Pre-COVID-19 Sera from Patients with Protozoan and Helminth Parasitic Infections.
Yansouni CP; Papenburg J; Cheng MP; Corsini R; Caya C; Vasquez Camargo F; Harrison LB; Zaharatos G; Büscher P; Faye B; Ndiaye M; Matlashewski G; Ndao M
J Clin Microbiol; 2022 Jan; 60(1):e0171721. PubMed ID: 34669455
[TBL] [Abstract][Full Text] [Related]
34. Integration of symptomatic, demographical and diet-related comorbidities data with SARS-CoV-2 antibody rapid diagnostic tests during epidemiological surveillance: a cross-sectional study in Jakarta, Indonesia.
Agustina R; Syam AF; Wirawan F; Widyahening IS; Rahyussalim AJ; Yusra Y; Rianda D; Burhan E; Salama N; Daulay R; Halim ARV; Shankar AH
BMJ Open; 2021 Aug; 11(8):e047763. PubMed ID: 34376448
[TBL] [Abstract][Full Text] [Related]
35. SARS-CoV-2 IgG/IgM Rapid Test as a Diagnostic Tool in Hospitalized Patients and Healthcare Workers, at a large Teaching Hospital in northern Italy, during the 2020 COVID-19 Pandemic.
Canetti D; Dell'Acqua R; Riccardi N; Della Torre L; Bigoloni A; Muccini C; Bruzzesi E; Ranzenigo M; Chiurlo M; Racca S; Galli C; Castagna A; Tambussi G; Lazzarin A
New Microbiol; 2020 Oct; 43(4):161-165. PubMed ID: 33135083
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of the performance of SARS--CoV--2 antibody assays for a longitudinal population-based study of COVID--19 spread in St. Petersburg, Russia.
Barchuk A; Shirokov D; Sergeeva M; Tursun Zade R; Dudkina O; Tychkova V; Barabanova L; Skougarevskiy D; Danilenko D
J Med Virol; 2021 Oct; 93(10):5846-5852. PubMed ID: 34081328
[TBL] [Abstract][Full Text] [Related]
37. Development and multi-center clinical trials of an up-converting phosphor technology-based point-of-care (UPT-POCT) assay for rapid COVID-19 diagnosis and prediction of protective effects.
Zhang P; Li B; Wang Y; Min W; Wang X; Zhou Y; Li Z; Zhao Y; Zhang H; Jiang M; Zheng H; Yang C; Zhang W; Zuo L; Gao Q; Yang Z; Li Y; Feng T; Lin C; Hu Q; Song T; Yang R
BMC Microbiol; 2022 Feb; 22(1):42. PubMed ID: 35114938
[TBL] [Abstract][Full Text] [Related]
38. Comparison of two antibody screening systems for SARS-CoV-2 antibody detection in recovered and vaccinated subjects - test performance and possible indicators for immunity.
Jonczyk R; Stanislawski N; Seiler LK; Ahani S; Bueltemeier A; Stahl F; Beutel S; Blume H; Hauß C; Melk A; Paulsen M; Stiesch M; Winkel A; Pott PC; Saletti G; González-Hernández M; Kaiser FK; Rimmelzwaan GF; Osterhaus ADME; Blume C
J Clin Virol; 2022 Dec; 157():105322. PubMed ID: 36279696
[TBL] [Abstract][Full Text] [Related]
39. Investigation and long-term monitoring of the presence of neutralizing antibody in patients with COVID-19 disease of different clinical severity.
Kaygusuz S; Korukluoğlu G; Coşgun Y; Şahin Ö; Arslan F
J Med Virol; 2022 Aug; 94(8):3596-3604. PubMed ID: 35365870
[TBL] [Abstract][Full Text] [Related]
40. Correlation of SARS-CoV-2 Neutralizing Antibodies to an Automated Chemiluminescent Serological Immunoassay.
Grenache DG; Ye C; Bradfute SB
J Appl Lab Med; 2021 Mar; 6(2):491-495. PubMed ID: 33098417
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]